mRNA profiling of TGFβ2 in 124 melanocytic lesions including nevi, MIS, primary and metastatic melanoma demonstrated a progressive decline in TGFβ2 expression from metastatic lesions, to deeper primary lesions, to superficial lesions to nevi [52]. Here, TGFB2 is linked to metastatic melanoma.